Загрузка...
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
The retained functionality of the sodium iodide symporter (NIS) expressed in differentiated thyroid cancer (DTC) cells allows the further utilization of post-surgical radioactive iodine (RAI) therapy, which is an effective treatment for reducing the risk of recurrence, and even the mortality, of DTC...
Сохранить в:
| Опубликовано в: : | Endocrinol Metab (Seoul) |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Endocrine Society
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6769341/ https://ncbi.nlm.nih.gov/pubmed/31565873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2019.34.3.215 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|